Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
- Status
- COMPLETED
- Phase
- PHASE3
Sitagliptin and Glucagon Counterregulation
- Status
- COMPLETED
- Phase
- PHASE4
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
- Status
- COMPLETED
- Phase
- PHASE3
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
- Status
- COMPLETED
- Phase
- PHASE3
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)
- Status
- COMPLETED
- Phase
- PHASE3
Promoting the Universal Medication Schedule Via Mobile and EHR Technologies
- Status
- COMPLETED
- Phase
- NA
The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
- Status
- COMPLETED
- Phase
- NA
Reducing Proviral HIV DNA With Interferon-a
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
- Status
- COMPLETED
- Phase
- N/A
A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
- Status
- COMPLETED
- Phase
- PHASE4